Evidence map›Paper›PMID 42008181›Full record

ArticlePituitary2026

Impact of granulation pattern on surgical and long-term outcomes in Cushing's disease: a comparative study of DGCT and SGCT.

Isabella Nasi-Kordhishti, Mirko Hladik, Felix Behling, Jens Schittenhelm, Jürgen Honegger

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Pituitary, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Isabella Nasi-KordhishtiDepartment of Neurosurgery and Neurotechnology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Hoppe-Seyler-Strasse 3, Tübingen, 72076, Germany. isabella.nasi-kordhishti@med.uni-tuebingen.de.ORCID http://orcid.org/0000-0003-2226-4958
Mirko HladikDepartment of Neurosurgery and Neurotechnology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Hoppe-Seyler-Strasse 3, Tübingen, 72076, Germany.
Felix BehlingDepartment of Neurosurgery and Neurotechnology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Hoppe-Seyler-Strasse 3, Tübingen, 72076, Germany.
Jens SchittenhelmCenter for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0002-9168-6209
Jürgen HoneggerDepartment of Neurosurgery and Neurotechnology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Hoppe-Seyler-Strasse 3, Tübingen, 72076, Germany.ORCID http://orcid.org/0000-0002-7249-8077

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFunctioning corticotroph adenomas/PitNETs can be subclassified into Densely and Sparsely Granulated Corticotroph Tumors (DGCT and SGCT). Previous studies suggest that DGCTs are associated with favourable outcomes, while SGCTs may be more aggressive. However, data comparing these subtypes in large cohorts remain limited. MATERIALS &

methodsWe performed a single-center retrospective analysis of 208 patients with CD who underwent TSS between 2004 and 2024. Of these, 175 had DGCT and 33 had SGCT. Data were collected on preoperative diagnostics and imaging, intraoperative findings and strategies, histopathology, and surgical early and long-term outcomes.

resultsWe found no significant differences in preoperative tumor characteristics or surgical approaches between DGCT and SGCT. However, SGCT patients presented with a shorter interval between symptom onset and surgery. DGCT patients exhibited higher early remission rates (96.9% vs. 87.1%) and lower long-term recurrence rates (9.3% vs. 12.9%). Histopathological analysis revealed higher MIB-1 indices and p53 expression in SGCT, indicating a more aggressive tumor phenotype.

conclusionDespite similar preoperative and intraoperative characteristics, SGCT was associated with a higher recurrence rate and more aggressive biological behavior. These findings emphasize the need for intensified follow-up and consideration of early adjuvant therapies for SGCT patients. Our study provides valuable insights into the management of DGCT and SGCT, suggesting that histological subtype plays a critical role in long-term prognosis and underscores the importance of tailored therapeutic strategies for these subtypes in CD.

Indexed as

ACTH-Secreting Pituitary AdenomaNeoplasm Recurrence, LocalPituitary ACTH HypersecretionAdenomaAdolescentAdultAgedChildFemaleHumansMaleMiddle AgedRetrospective StudiesTreatment OutcomeYoung AdultCorticotroph adenomaCushing’s diseaseDensely granulatedHistological subtypeLong-term outcomePitNETRecurrenceRemissionSparsely granulated

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.